NYSE - Nasdaq Real Time Price USD
Bio-Rad Laboratories, Inc. (BIO-B)
234.41
0.00
(0.00%)
As of April 21 at 11:41:26 AM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 6 | 6 |
Avg. Estimate | 573.23M | 632.08M | 2.57B | 2.68B |
Low Estimate | 565.1M | 624.9M | 2.53B | 2.61B |
High Estimate | 580.4M | 644.9M | 2.63B | 2.73B |
Year Ago Sales | 610.82M | 638.48M | 2.57B | 2.57B |
Sales Growth (year/est) | -6.15% | -1.00% | -0.03% | 4.55% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
BIO-B | -- | -- | -- | -- |
S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Related Tickers
AVNS Avanos Medical, Inc.
12.52
-1.49%
APYX Apyx Medical Corporation
1.0213
+13.48%
ENOV Enovis Corporation
34.18
-2.11%
ITGR Integer Holdings Corporation
124.79
-1.69%
NUWE Nuwellis, Inc.
0.9601
-3.99%
IRTC iRhythm Technologies, Inc.
106.98
+0.32%
IINN Inspira Technologies Oxy B.H.N. Ltd.
0.5904
-3.21%
BJDX Bluejay Diagnostics, Inc.
1.9800
+2.07%
AMIX Autonomix Medical, Inc.
2.3200
-8.28%
CATX Perspective Therapeutics, Inc.
2.3950
-0.62%